The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of the sale of an unregistered Ceftriaxone Sodium Injection brand known as ZACEF-TZ Injection. This product was discovered following an investigation into a consumer complaint received by the post-marketing surveillance (PMS) unit of the Agency in FCT, Abuja.
The investigation resulted in the mop-up of the offending product within the FCT and further directives to all NAFDAC zonal directors and state coordinators to carry out surveillance and mop up the unregistered product within the zones and states.
Ceftriaxone & Tazobactam Injection is a combination antibiotic that is used for the treatment of Bacterial Infections, Surgical Site Infections, Lyme Disease, Typhoid, Paratyphoid, Bone and joint infections, Community-acquired pneumonia, Intra-abdominal infections, Pelvic inflammatory disease, Uncomplicated gonorrhea, Skin and skin structure infections, Septicaemia, Urinary tract infections, and other conditions.
Risk Statement
The illegal marketing of substandard and falsified medicines poses a risk to the health of people, since by not complying with the regulatory provisions, the safety, quality, and efficacy of the products are not guaranteed.
Product details
The details of the product are as follows;
| Product Name | Batch No. | Manufacturing date | Expiry date | Stated NRN | Manufactured for | Marketed by |
| ZACEF-TZ Injection (Ceftriaxone Sodium + Tazobactam Sodium) | C-2308-02A
| 08/2023 | 07/2025
| A-46344 | JioPharm International, sco 12 New Nirmal Market, Karnal (HRY) India | JAC Pharmaceuticals Ltd, No.1 Olojojo Street, Oworo, Lagos, Nigeria. |
Please note that the above NRN (NAFDAC Registration Number A-46344) stated on the product is falsified and does not exist in the NAFDAC database. The product has no manufacturer details and no patient information leaflet inserted in the secondary pack. The product is similar (sound-alike) to a registered drug product EXACEF-TZ Injection (Ceftriaxone Sodium + Tazobactam Sodium) with the same active ingredient combination.
Product picture
Importers, distributors, retailers, healthcare professionals, and caregivers are hereby advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of substandard and falsified products. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng
NAFDAC……..Customer-focused, Agency-minded!!!
Signed Management
